OGN -.71 to 16.54, the relentless selloff continues. It keeps getting cheaper every day so I'm not feeling very motivated to add to my small position. The latest news on "The Fly" was positive - new analyst coverage with an "Overweight" rating -
fly (9/21) -
Barclays analyst Balaji Prasad initiated coverage of Organon with an Overweight rating and $28 price target. The firm says Organon is a global play and leader in women's specialty. The company is seeing "rapid growth" in biosimilars that can together offset the decline in its brands portfolio, the analyst tells investors in a research note.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.